Autologous MUC1-Specific Th1 Effector Cell Immunotherapy Induce Differential Levels of Systemic TReg Cell Subpopulations That Result in Increased Ovarian Cancer Patient Survival

Adoptive T cell immunotherapy using autologous lymphocytes is a viable treatment for patients with cancer and requires participation of Ag-specific CD4 and CD8 T cells. Here, we assessed the immunotherapeutic effects of autologous MUC1 peptide-stimulated CD4(+) effector cells following adoptive tran...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Dobrzanski, Mark J., Rewers-Felkins, Kathleen A., Quinlin, Imelda S., Samad, Khaliquzzaman A., Phillips, Catherine A., Robinson, William, Dobrzanski, David J., Wright, Stephen E.
Format: Artigo
Jezik:Inglês
Izdano: 2009
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC2805085/
https://ncbi.nlm.nih.gov/pubmed/19762283
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clim.2009.08.007
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki